Status:
UNKNOWN
Autograft of Human Ovarian Tissue : Efficiency and Safety
Lead Sponsor:
Assistance Publique - Hôpitaux de Paris
Collaborating Sponsors:
Agence de La Biomédecine
Conditions:
Ovarian Tissue Transplantation
Eligibility:
FEMALE
18-45 years
Phase:
NA
Brief Summary
Ovarian tissue cryopreservation is a new technique for female fertility preservation. One way to restore fertility is autotransplantation of ovarian tissue. The principal purpose of this study will b...
Detailed Description
Ovarian tissue cryopreservation is a new technique for female fertility preservation before gonadotoxic treatments. The first ovarian tissue cryopreservations were performed 10 years ago. There are tw...
Eligibility Criteria
Inclusion
- Inclusion criteria :
- adult women (age ≥ 18 years old) who stored ovarian fragments before gonadotoxic treatments
- Women who desire to conceive
- Married women or in stable couple
- Cured women or in remission
- Women suffering of Premature ovarian failure
- Consenting women
- women with health insurance
- Exclusion criteria :
- age \< 18 years
- women with normal ovarian function
- women with a disease at high risk for ovarian metastasis
- women with contraindication for surgery
- women with contraindication for pregnancy
- not cured women or not in remission
- women without health insurance
Exclusion
Key Trial Info
Start Date :
June 1 2010
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
January 1 2019
Estimated Enrollment :
40 Patients enrolled
Trial Details
Trial ID
NCT02184806
Start Date
June 1 2010
End Date
January 1 2019
Last Update
November 6 2017
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Hôpital Tenon, service de Biologie de la reproduction
Paris, France, 75020